Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.10.11.756515

The ammonia-senescence ratchet drives an adaptation-senescence-ammonioptosis transition in liver cancer

Abstract

Senescence suppresses tumor proliferation while exposing survival dependencies, motivating separate, sequential steps of senescence induction and senescent-cell clearance. Whether senescence-sustaining metabolism can instead be overdriven to trigger cell-autonomous death remains unknown. Senescent cells generate ammonia through glutaminolysis to buffer intracellular acidification, yet extracellular ammonia can impair anti-tumor immunity, leaving unexplored whether ammonia can instead drive tumor-cell-intrinsic death. Here, we reverse this logic and identify a self-reinforcing ammonia-senescence ratchet in which ammonia accumulation promotes senescence, whereas senescence reciprocally enhances ammoniagenesis, progressively driving tumor cells from metabolic adaptation through senescence to ammonioptosis. Reducing intracellular ammonia suppressed senescence and cell death, whereas ammonia repletion restored lethality. We engineered acid-responsive H3B-120@CoGd-LDH (HBCG) to preferentially amplify tumor-cell ammonia by reinforcing senescence and ammoniagenesis, restricting ammonia disposal and weakening lysosomal buffering. HBCG limited extracellular ammonia accumulation and CD8+ T-cell exposure in co-cultures, induced ammonioptosis in patient-derived liver-cancer organoids and suppressed tumor growth in immunocompetent mice. This work reveals that adaptation, senescence and ammonioptosis can be connected through escalating intracellular ammonia stress, providing a mechanistic framework for understanding stress-driven tumor-cell fate transitions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Han, Y., Huang, M., Xie, Y., Zhang, S., Wang, J., Han, L., Li, C., Zhang, Y.. 2026-10-13. The ammonia-senescence ratchet drives an adaptation-senescence-ammonioptosis transition in liver cancer. https://doi.org/10.64898/2026.10.11.756515

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Mesoscale Soft Robotics for Mechanically Perturbing and Functionally Monitoring Responses in Human Organoids

Human organoids represent promising models for studies of significance to the biology and medical communities. Of the existing approaches for monitoring organoids, none offers the ability to apply programmable mechanical forces while simultaneously recording multi-modal physiological responses, of relevance to phenomena spanning from traumatic brain injuries to cardiac rhythm disorders. Here, we present a mesoscale soft robotic organoid interface that enables programmable delivery of forces to organoids of diverse shapes, and to map electrophysiological activity and mechanical responses. The platform combines actuation elements with integrated sensors for quantitative measurement and control. Studies using this technology reveal that spheroidal cortical organoids exhibit distinct responses to mechanical trauma, including silencing, recovery, and changes in neuronal firing patterns. Additional experiments on cardiac ring tissues demonstrate that sustained stretching induces beat-to-beat rhythm variability and altered conduction. The results establish a framework for investigating force-triggered transitions between physiological and disease-like states in human tissue models.

bioengineering↗

Few-shot regulatory sequence design with a genomic language model

A central challenge in generative biology is translating knowledge learned from natural sequences and experiments into designs with desired functions. In-context learning (ICL) is an emergent capability of large language models that allows them to adapt to new tasks from a few examples without additional training, enabling these models to become general-purpose learners. Here, we show that the genome language model, Evo 2, exhibits generative ICL in biological sequence design. Prompting with just tens of examples conditions Evo 2 to generate novel and diverse regulatory DNA sequences without any additional training. Mechanistic analysis suggests that genomic ICL may originate from induction, similar to phenomena observed in natural language. Reinforcement learning leveraging sequence-to-function models as experiment-derived rewards further strengthens ICL. We first validate this approach by generating enhancers that drive cell-type-specific gene expression in three human cell lines. Extending this approach in vivo, enhancers designed using human regulatory element data selectively label layer 5 extratelencephalic neurons in the mouse cortex with high specificity and stronger activity than existing enhancers. Our study provides evidence of emergent properties in genomic sequence models and introduces a promising approach for improving functional conditioning in generative biology.

bioengineering↗

IOP-independent treatment for neurodegeneration in glaucoma using optimized ROS-scavenging microparticles for sustained release of erythropoietin

Glaucoma is a slow-progressing neurodegenerative disease of the optic projection to the brain and a leading cause of blindness worldwide. Current treatments are targeted towards lowering intraocular pressure (IOP), the only known, modifiable risk factor; however, this strategy is ineffective in many patients. An early hallmark of glaucomatous neurodegeneration is increased reactive oxygen species (ROS), representing an alternative opportunity for intervention to halt or slow disease progression. In this work, we optimize a ROS-scavenging copolymer, poly(propylene sulfide-co-ethylene sulfide) (PPSES), for formulation of size-controlled, stabilized, antioxidant microparticles (MPs) for sustained release of the protein erythropoietin (EPO). EPO promotes biological antioxidant defense via activation of NRF2-mediated transcription of antioxidant genes. This MP system overcomes the short half-life of EPO and leverages the combined benefits of bioactive EPO with long-lasting, inherently antioxidant PPSES MPs. The lead EPO-MP formulation preserves neurons in both mouse and non-human primate models of glaucoma through suppression of oxidative stress and optic nerve degeneration. EPO-loaded PPSES MPs represent a translationally relevant therapy for long-term management of glaucoma independent of IOP.

bioengineering↗